Drug discovery using machine learning
The problem
Early-stage drug discovery is a risky and expensive endeavor, limiting innovation.
The solution
Applying machine learning to drug discovery to lower the cost and open up routes to novel medicines.
Our engagement
Anterra led the Seed investment round supporting the spin-out of ZebiAI from X-Chem.
Our other companies
Food marketplace helping people eat better effortlessly
Digital procurement platform for farm inputs and services
Innovative materials to extend fresh produce shelf life
Real-time data collection tools for farm machinery
Financial and data services for the fresh produce industry
Next-generation synthetic cellular controls
Genome engineering using CRSPR-Cas9
Novel flavor generation using modified brewer’s yeast
Plant-based enteral nutrition products
Microbiome innovation for animal health